Logo image of GPUS

HYPERSCALE DATA INC (GPUS) Stock Fundamental Analysis

NYSEARCA:GPUS - NYSE Arca - US09175M8047 - Common Stock - Currency: USD

1.325  -0.1 (-7.34%)

Fundamental Rating

2

Taking everything into account, GPUS scores 2 out of 10 in our fundamental rating. GPUS was compared to 6 industry peers in the Industrial Conglomerates industry. Both the profitability and financial health of GPUS have multiple concerns. GPUS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

GPUS had negative earnings in the past year.
GPUS had a negative operating cash flow in the past year.
In the past 5 years GPUS always reported negative net income.
In the past 5 years GPUS reported 4 times negative operating cash flow.
GPUS Yearly Net Income VS EBIT VS OCF VS FCFGPUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

GPUS has a worse Return On Assets (-32.08%) than 83.33% of its industry peers.
GPUS has a worse Return On Equity (-1111.08%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -32.08%
ROE -1111.08%
ROIC N/A
ROA(3y)-45.99%
ROA(5y)-36.36%
ROE(3y)-439.95%
ROE(5y)-278.29%
ROIC(3y)N/A
ROIC(5y)N/A
GPUS Yearly ROA, ROE, ROICGPUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 13.92%, GPUS is in line with its industry, outperforming 50.00% of the companies in the same industry.
GPUS's Gross Margin has improved in the last couple of years.
GPUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.3%
GM growth 5Y10.66%
GPUS Yearly Profit, Operating, Gross MarginsGPUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

GPUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GPUS has been increased compared to 1 year ago.
GPUS has more shares outstanding than it did 5 years ago.
GPUS has a worse debt/assets ratio than last year.
GPUS Yearly Shares OutstandingGPUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
GPUS Yearly Total Debt VS Total AssetsGPUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -5.27, we must say that GPUS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GPUS (-5.27) is better than 66.67% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that GPUS is not too dependend on debt financing.
GPUS has a Debt to Equity ratio of 0.13. This is amongst the best in the industry. GPUS outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -5.27
ROIC/WACCN/A
WACC10.7%
GPUS Yearly LT Debt VS Equity VS FCFGPUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 0.28 indicates that GPUS may have some problems paying its short term obligations.
With a Current ratio value of 0.28, GPUS is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
A Quick Ratio of 0.28 indicates that GPUS may have some problems paying its short term obligations.
GPUS has a Quick ratio of 0.28. This is amonst the worse of the industry: GPUS underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
GPUS Yearly Current Assets VS Current LiabilitesGPUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

GPUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.29%, which is quite impressive.
The Revenue for GPUS has decreased by -41.22% in the past year. This is quite bad
GPUS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.68% yearly.
EPS 1Y (TTM)95.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1736.67%
Revenue 1Y (TTM)-41.22%
Revenue growth 3Y26.73%
Revenue growth 5Y36.68%
Sales Q2Q%-44.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GPUS Yearly Revenue VS EstimatesGPUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GPUS Yearly EPS VS EstimatesGPUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 -5K -10K -15K

0

4. Valuation

4.1 Price/Earnings Ratio

GPUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GPUS Price Earnings VS Forward Price EarningsGPUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GPUS Per share dataGPUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GPUS!.
Industry RankSector Rank
Dividend Yield N/A

HYPERSCALE DATA INC

NYSEARCA:GPUS (6/25/2025, 2:22:31 PM)

1.325

-0.1 (-7.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)04-15 2025-04-15
Earnings (Next)N/A N/A
Inst Owners1.64%
Inst Owner Change-9%
Ins Owners0.21%
Ins Owner Change7.42%
Market Cap9.57M
Analysts82.86
Price TargetN/A
Short Float %25.86%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.98
Dividend Growth(5Y)N/A
DP-8.53%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 2.08
EV/EBITDA N/A
EPS(TTM)-65.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.77
FCFYN/A
OCF(TTM)-1.82
OCFYN/A
SpS14.39
BVpS0.87
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.08%
ROE -1111.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.92%
FCFM N/A
ROA(3y)-45.99%
ROA(5y)-36.36%
ROE(3y)-439.95%
ROE(5y)-278.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-25.3%
GM growth 5Y10.66%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.8%
Cap/Sales 6.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z -5.27
F-Score3
WACC10.7%
ROIC/WACCN/A
Cap/Depr(3y)200.34%
Cap/Depr(5y)1362.93%
Cap/Sales(3y)34.08%
Cap/Sales(5y)78.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1736.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.22%
Revenue growth 3Y26.73%
Revenue growth 5Y36.68%
Sales Q2Q%-44.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y71.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-243.54%
OCF growth 3YN/A
OCF growth 5YN/A